Nutrition Throughout the Treatment Course - Expanding Care From Hospital to Home
- Conditions
- Head and Neck Cancer
- Registration Number
- NCT05997329
- Lead Sponsor
- University of Oslo
- Brief Summary
Patients with cancer have increased risk of malnutrition due to the disease itself and the treatment regimen they undergo. This is particularly relevant for patients with head and neck cancer (HNC), where 74%-95% are malnourished. HNC is a heterogenous group of cancers, including oral cavity, larynx, pharynx and salivary glands. The present project will study the effectiveness and implementation of remote patient monitoring of nutrition and tailored nutrition support throughout the treatment course in patients with head and neck cancer. The implementation will be evaluated in a randomized controlled trial (RCT), and the aim of the project is to reduce the prevalence of malnutrition and increase the quality of life among patients with HNC.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- All
- Target Recruitment
- 125
- Head and neck cancer
- Older than 18 years
- Patients admitted with the classification of malignant tumors (TNM) stage 4
- Terminal condition (life expectancy < 6 months)
- Patients who do not understand the Norwegian language.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Malnutrition_PGSGA 18 weeks Measured by the: Patient-Generated Subjective Global Assessment (PG-SGA). The tool categories participants into: category A (Well-nourished), B (Moderately malnutrition or possible malnutrition), or C (serious malnutrition)
- Secondary Outcome Measures
Name Time Method Malnutrition GLIM 18 weeks Malnutrition measured by the objective method developed by the Global Leadership Initiative on Malnutrition (GLIM). The GLIM-criteria also categories the participants i three groups: Well-nourished, moderate malnutrition and severe malnutrition.
Nutrition intake 18 weeks 24-hour recall interviews
Health-related quality of life 18 weeks EuroQol Research Foundation, Netherlands (EQ5D-5L). Assess health in 5 dimensions each of which has three response levels (1: No problems, 2: some problems and 3: extreme problems/unable to do).
Number of Participants compliant to the intervention 18 weeks Review of reported use of the MyFood app in the electronic patient record
Number of patients with non-elective readmissions 18 weeks Review of readmissions in the electronic patient record
Weight change 18 weeks weight measurements
Body composition 18 weeks Bioelectrical Impedance Analysis (BIA)
Trial Locations
- Locations (2)
University of Oslo
🇳🇴Oslo, Oslo County, Norway
Oslo University Hospital
🇳🇴Oslo, Norway
University of Oslo🇳🇴Oslo, Oslo County, NorwayChristine Henriksen, PhDContact+4799003128christine.henriksen@medisin.uio.no